Connection
Sabrina Spencer to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Sabrina Spencer has written about Drug Resistance, Neoplasm.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.414 |
|
|
|
-
Sine CC, Watts LP, Fernandez B, Marikar N, Wang J, Knudsen ES, Witkiewicz AK, Spencer SL. p16 expression confers sensitivity to CDK2 inhibitors in cyclin E1-driven ovarian cancers. Sci Signal. 2025 Nov 25; 18(914):eadv0415.
Score: 0.156
-
Nangia V, Ashraf H, Marikar N, Passanisi VJ, Ill CR, Spencer SL. MAPK and mTORC1 signaling converge to drive cyclin D1 protein production to enable cell cycle reentry in melanoma persister cells. Sci Signal. 2025 Sep 02; 18(902):eadw3231.
Score: 0.154
-
Flusberg DA, Roux J, Spencer SL, Sorger PK. Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes. Mol Biol Cell. 2013 Jul; 24(14):2186-200.
Score: 0.066
-
Khong A, Ripin N, de Vasconcelos LM, Passanisi V, Spencer S, Parker R. Stress granules promote quiescence by enhancing p21 levels and reducing phospho-Rb. RNA. 2025 09 16; 31(10):1472-1487.
Score: 0.039